Header Logo
Newsletter Podcast
Log In
← Back to all posts

PRP Wins Big, Raise Your Rates, Master Your Marketing

Apr 22, 2025
Connect

Highlights

  • Today’s Research Article: PRP delivers twice the healing at six months compared to steroids — and helps patients avoid surgery.

  • Questions from the Field: When your results are better, your price should be too — charge for the quality and outcomes you deliver.

  • Let’s Get Down to Business: If patients can’t find you online, they’ll never book — make digital marketing your best closer.

  • Come Join Us: Level up your skills and network with the best at these must-attend orthobiologics events!

If this newsletter was forwarded to you and you'd like to receive future updates directly, subscribe here.


Today’s Research Article

Autologous Platelet‐rich Plasma versus Corticosteroid in the Management of Elbow Epicondylitis: A Randomized Study

Ankit Varshney, Rajesh Maheshwari, Anil Juyal, Atul Agrawal, Prabhnoor Hayer

Read the full article here.

Summary:

In this randomized study by Varshney et al., 112 patients with elbow epicondylitis were treated with either a corticosteroid injection or autologous platelet-rich plasma (PRP) injection and followed for six months. Both groups showed comparable pain and function improvement at 1 and 2 months, but significant differences emerged later: at 6 months, PRP patients had a 91% improvement in pain scores compared to 42.2% in the steroid group, and a 54.4% improvement in function scores versus only 1.25% with steroids. Importantly, no complications such as infections were reported, although mild post-injection pain was noted.

The findings suggest that while corticosteroids provide short-term relief, PRP leads to superior and longer-lasting improvements by promoting true healing at the tendon level. PRP offers a regenerative treatment approach, whereas steroids mainly suppress inflammation temporarily and may cause structural tendon changes over time. The study concludes that PRP should be considered as a primary nonsurgical option for managing elbow epicondylitis, especially for patients who seek durable recovery without the risks of tendon degeneration.

Talking Points for Doctors to Patients: Why Choose PRP

Subscribe to keep reading this post

Subscribe

Already have an account? Log in

Loading...
Evidence, Earnings, Elevation: PRP Outcomes, Pricing & Events
Highlights Today’s Research Article: Early OA? One injection of PRP or HA helps—PRP moves the needle faster.   Questions from the Field: If you measure it, you can price it—structure PRP fees around proven value.   Let’s Get Down to Business: Reclaim your practice—innovate clinically, communicate publicly, mentor boldly.   Come Join Us - Your October sprint: TrueMD Live → ICRS → Apex L...
PRP Research. Real-World Tips. All Roads Lead to TrueMD Live
Highlights Today’s Research Article: PRP beats steroids & PT in SAIS: more pain relief, better function, better QoL at 8 weeks. Questions from the Field: Short-axis halo first, then long-axis—radial or ulnar entry both safe in the median-ulnar “safe zone.” Let’s Get Down to Business: Pick one vivid patient avatar to attract the right clients—and stop saying yes to the wrong ones. Come ...
PRP Evidence, Branding for Doctors & Join Us Live Sept 18
Highlights Today’s Research Article: PRP halved knee-OA pain and boosted function at 6 months—double-blind, same-patient control. Questions from the Field: Yes—drain the effusion, then PRP same day to avoid dilution and clear catabolic enzymes. Let’s Get Down to Business: Patients choose connection over credentials—your personal brand is the clinical edge. Come Join Us: Live PRP demo +...

The OBX Brief

Your guide to Orthobiologics Literature
Footer Logo
Newsletter Podcast
© 2025 Kajabi
Powered by Kajabi

Join Our Free Trial

Get started today before this once in a lifetime opportunity expires.